Tumor Detection, Metastasis & Radiation Therapy Use Case

STAGE helps to provide a robust collection of contrast outputs which can help further differentiate tumor tissue and the changes occurring in surrounding tissue.

What do we look for?

  • T1 and PD Properties Demonstrate Water Content Changes
  • Leaky Vessels May Develop Bleeding

Tumor tissue may form weak-walled vascular structures which are prone to bleeding. The susceptibility-based contrasts from STAGE are sensitive to visualizing tumor-associated blood products.

New & Related

All Resources

ISNVD’s 2021 Webinar

This January, SpinTech participated in ISNVD's annual global webinar "Approaches and Applications of Multi-Contrast Quantitative Imaging". SpinTech founder, Mark Haacke, PhD, had the opportunity to discuss STAGE in relation to the collection of big data...

read more
NeuroCOVID’s Impact on Standard Radiology Protocols

NeuroCOVID’s Impact on Standard Radiology Protocols

In the wake of the SARS-CoV-2 virus, many areas of medical research were put on hold so the community could focus on treatments, vaccines and preventive measures. As the new COVID-19 vaccines begin going public, it’s likely that the general public’s concerns about the...

read more